Growth at Reasonable Price
Results
4
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PHM | €75.45 | 9.1% | -4.9% | €1.3b | €104.89 | 16.3 | 31.8% | 1.1% | Pharmaceuticals & Biotech | ||
TUB | €3.35 | 3.6% | -17.4% | €411.1m | €4.17 | 0.6 | 75.5% | 6.1% | Materials | ||
ROVI | €57.85 | -2.1% | 4.6% | €3.0b | €75.38 | 22.4 | 16.6% | 1.7% | Pharmaceuticals & Biotech | ||
IDR | €47.92 | -10.2% | 33.1% | €8.4b | €66.07 | 18.6 | 14.4% | 0.6% | Software |
Page 1 of 1